Clinical Trials
2 trialsNCT07120451 2025-08-13
Combination Therapy of Senaparib and Bevacizumab for First-line Maintenance Therapy in Newly Diagnosed Advanced Homologous Recombination Proficient Ovarian Cancer Based on Exosome Protein Marker
Fudan University
Phase 2 Not yet recruiting
NCT05794659 2023-07-20
Cornerstone4
Aston Sci. Inc.
Phase 2 Not yet recruiting